{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:36:03Z","timestamp":1788575763707,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic\/Technology Research Leader","doi-asserted-by":"crossref","award":["18XD1402600"],"award-info":[{"award-number":["18XD1402600"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Municipal Human Resources Development Program for Outstanding Leaders","award":["2017BR036"],"award-info":[{"award-number":["2017BR036"]}]},{"name":"Shanghai Municipal Education Commission -Gaofeng Clinical Medicine Grant Support","award":["20171926"],"award-info":[{"award-number":["20171926"]}]},{"name":"Science\u00a0and\u00a0Technology\u00a0Development \u00a0Fund\u00a0of\u00a0Pudong\u00a0New\u00a0Area\u00a0of\u00a0Shanghai","award":["PKJ2017-Y03"],"award-info":[{"award-number":["PKJ2017-Y03"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572330"],"award-info":[{"award-number":["81572330"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871727"],"award-info":[{"award-number":["81871727"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472624"],"award-info":[{"award-number":["81472624"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772941"],"award-info":[{"award-number":["81772941"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key\u00a0Program\u00a0of the\u00a0National\u00a0Natural\u00a0Science\u00a0Foundation","award":["81930066"],"award-info":[{"award-number":["81930066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>N<jats:sup>6<\/jats:sup>-Methyladenosine (m<jats:sup>6<\/jats:sup>A) modification has been implicated in many biological processes. It is important for the regulation of messenger RNA (mRNA) stability, splicing, and translation. However, its role in cancer has not been studied in detail. Here we investigated the biological role and underlying mechanism of m<jats:sup>6<\/jats:sup>A modification in hepatoblastoma (HB).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used Reverse transcription quantitative real-time PCR (RT-qPCR) and Western blotting to determine the expression of m<jats:sup>6<\/jats:sup>A related factors. And we clarified the effects of these factors on HB cells using cell proliferation assay, colony formation, apoptotic assay. Then we investigated of methyltransferase-like 13 (METTL3) and its correlation with clinicopathological features and used xenograft experiment to check METTL3 effect in vivo. m<jats:sup>6<\/jats:sup>A-Seq was used to profiled m<jats:sup>6<\/jats:sup>A transcriptome-wide in hepatoblastoma tumor tissue and normal tissue. Finally, methylated RNA immunoprecipitation (MeRIP) assay, RNA remaining assay to perform the regulator mechanism of MEETL3 on the target CTNNB1 in HB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this research, we discovered that m<jats:sup>6<\/jats:sup>A modifications are increased in hepatoblastoma, and METTL3 is the main factor involved with aberrant m<jats:sup>6<\/jats:sup>A modification. We also profiled m<jats:sup>6<\/jats:sup>A across the whole transcriptome in hepatoblastoma tumor tissues and normal tissues. Our findings suggest that m<jats:sup>6<\/jats:sup>A is highly expressed in hepatoblastoma tumors. Also, m<jats:sup>6<\/jats:sup>A is enriched not only around the stop codon, but also around the coding sequence (CDS) region. Gene ontology analysis indicates that m<jats:sup>6<\/jats:sup>A mRNA methylation contributes significantly to regulate the Wnt\/\u03b2-catenin pathway. Reduced m<jats:sup>6<\/jats:sup>A methylation can lead to a decrease in expression and stability of the CTNNB1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall our findings suggest enhanced m<jats:sup>6<\/jats:sup>A mRNA methylation as an oncogenic mechanism in hepatoblastoma, METTL3 is significantly up-regulated in HB and promotes HB development. And identify CTNNB1 as a regulator of METTL3 guided m<jats:sup>6<\/jats:sup>A modification in HB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12943-019-1119-7","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T08:03:38Z","timestamp":1577088218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":140,"title":["m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixuan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"key":"1119_CR1","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/pbc.24219","volume":"59","author":"AD Trobaugh-Lotrario","year":"2012","unstructured":"Trobaugh-Lotrario AD, Katzenstein HM. Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies. Pediatr Blood Cancer. 2012;59:809\u201312.","journal-title":"Pediatr Blood Cancer"},{"key":"1119_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.semdp.2016.12.015","volume":"34","author":"D Sharma","year":"2017","unstructured":"Sharma D, Subbarao G, Saxena R. Hepatoblastoma. Semin Diagn Pathol. 2017;34:192\u2013200.","journal-title":"Semin Diagn Pathol"},{"key":"1119_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/MOP.0000000000000042","volume":"26","author":"RL Meyers","year":"2014","unstructured":"Meyers RL, Tiao G, de Ville de Goyet J, Superina R, Aronson DC. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Curr Opin Pediatr. 2014;26:29\u201336.","journal-title":"Curr Opin Pediatr"},{"key":"1119_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/bjs.9681","volume":"102","author":"R Venkatramani","year":"2015","unstructured":"Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015;102:108\u201313.","journal-title":"Br J Surg"},{"key":"1119_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.02.051","volume":"375","author":"XJ Yuan","year":"2016","unstructured":"Yuan XJ, Wang HM, Jiang H, Tang MJ, Li ZL, Zou X, Fang YJ, Pan C, Tou JF, Zhang KR, et al. Multidisciplinary effort in treating children with hepatoblastoma in China. Cancer Lett. 2016;375:39\u201346.","journal-title":"Cancer Lett"},{"key":"1119_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","volume":"13","author":"JO Russell","year":"2018","unstructured":"Russell JO, Monga SP. Wnt\/beta-catenin signaling in liver development, homeostasis, and pathobiology. Annu Rev Pathol. 2018;13:351\u201378.","journal-title":"Annu Rev Pathol"},{"key":"1119_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.15252\/emmm.201707814","volume":"9","author":"S Crippa","year":"2017","unstructured":"Crippa S, Ancey PB, Vazquez J, Angelino P, Rougemont AL, Guettier C, Zoete V, Delorenzi M, Michielin O, Meylan E. Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma. EMBO Mol Med. 2017;9:1589\u2013604.","journal-title":"EMBO Mol Med"},{"key":"1119_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D Lopez-Terrada","year":"2009","unstructured":"Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and notch pathway activation in DLK+ precursors. Hum Pathol. 2009;40:783\u201394.","journal-title":"Hum Pathol"},{"key":"1119_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/cas.12655","volume":"106","author":"E Ashihara","year":"2015","unstructured":"Ashihara E, Takada T, Maekawa T. Targeting the canonical Wnt\/beta-catenin pathway in hematological malignancies. Cancer Sci. 2015;106:665\u201371.","journal-title":"Cancer Sci"},{"key":"1119_CR10","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","volume":"21","author":"K Taniguchi","year":"2002","unstructured":"Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, et al. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 2002;21:4863\u201371.","journal-title":"Oncogene"},{"key":"1119_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136.","journal-title":"Nature"},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"},{"key":"1119_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, et al. Nuclear m (6) a reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507\u201319.","journal-title":"Mol Cell"},{"key":"1119_CR14","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Wang TT, Xu QG, Zhou WP, Sun SH. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N (6) -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65:529\u201343.","journal-title":"Hepatology"},{"key":"1119_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-018-0590-8","volume":"11","author":"Y Pan","year":"2018","unstructured":"Pan Y, Ma P, Liu Y, Li W, Shu Y. Multiple functions of m (6) a RNA methylation in cancer. J Hematol Oncol. 2018;11:48.","journal-title":"J Hematol Oncol"},{"key":"1119_CR16","doi-asserted-by":"crossref","unstructured":"Tong J, Flavell RA, Li HB. RNA m (6) a modification and its function in diseases. Front Med. 2018;12:481\u20139","DOI":"10.1007\/s11684-018-0654-8"},{"key":"1119_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m (6) a decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28:616\u201324.","journal-title":"Cell Res"},{"key":"1119_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","volume":"69","author":"J Wen","year":"2018","unstructured":"Wen J, Lv R, Ma H, Shen H, He C, Wang J, Jiao F, Liu H, Yang P, Tan L, et al. Zc3h13 regulates nuclear RNA m (6) a methylation and mouse embryonic stem cell self-renewal. Mol Cell. 2018;69:1028\u201338 e1026.","journal-title":"Mol Cell"},{"key":"1119_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"1119_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-018-0843-z","volume":"9","author":"M Sorci","year":"2018","unstructured":"Sorci M, Ianniello Z, Cruciani S, Larivera S, Ginistrelli LC, Capuano E, Marchioni M, Fazi F, Fatica A. METTL3 regulates WTAP protein homeostasis. Cell Death Dis. 2018;9:796.","journal-title":"Cell Death Dis"},{"key":"1119_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","volume":"63","author":"P Wang","year":"2016","unstructured":"Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016;63:306\u201317.","journal-title":"Mol Cell"},{"key":"1119_CR22","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1038\/s41467-018-06898-4","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang Y, Li J, Sheng R, Deng P, Wang Y, et al. Mettl3-mediated m (6) a RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis. Nat Commun. 2018;9:4772.","journal-title":"Nat Commun"},{"key":"1119_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cr.2014.162","volume":"25","author":"MS Ben-Haim","year":"2015","unstructured":"Ben-Haim MS, Moshitch-Moshkovitz S, Rechavi G. FTO: linking m6A demethylation to adipogenesis. Cell Res. 2015;25:3\u20134.","journal-title":"Cell Res"},{"key":"1119_CR24","doi-asserted-by":"publisher","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","volume":"289","author":"C Xu","year":"2014","unstructured":"Xu C, Liu K, Tempel W, Demetriades M, Aik W, Schofield CJ, Min J. Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation. J Biol Chem. 2014;289:17299\u2013311.","journal-title":"J Biol Chem"},{"key":"1119_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, Vagbo CB, Shi Y, Wang WL, Song SH, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49:18\u201329.","journal-title":"Mol Cell"},{"key":"1119_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian SB, Jaffrey SR. 5\u2032 UTR m (6) a promotes cap-independent translation. Cell. 2015;163:999\u20131010.","journal-title":"Cell"},{"key":"1119_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Chen Y, Sulman EP, Xie K, Bogler O, et al. m (6) a Demethylase ALKBH5 maintains Tumorigenicity of Glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31:591\u2013606 e596.","journal-title":"Cancer Cell"},{"key":"1119_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, Huang H, Nachtergaele S, Dong L, Hu C, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N (6)-Methyladenosine RNA Demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"1119_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB. Dynamic m (6) a mRNA methylation directs translational control of heat shock response. Nature. 2015;526:591\u20134.","journal-title":"Nature"},{"key":"1119_CR30","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"1119_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, Bouley DM, Lujan E, Haddad B, Daneshvar K, et al. m (6) a RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707\u201319.","journal-title":"Cell Stem Cell"},{"key":"1119_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb2902","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol. 2014;16:191\u20138.","journal-title":"Nat Cell Biol"}],"updated-by":[{"DOI":"10.1186\/s12943-020-1136-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-019-1119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-019-1119-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-019-1119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:14:59Z","timestamp":1608596099000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-019-1119-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1186\/s12943-019-1119-7","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12943-020-1136-6","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"25 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After the publication of this work [1], the authors noticed that the affiliations were incorrectly provided. Updated affiliation section is provided in this paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the collection of specimens and animal handling in this work was reviewed and approved by the Medical Ethics Committee of the Shanghai Children\u2019s Medical Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}